Profil
Richard W.
Frazee is the founder of Secretory IgA, Inc. Prior to founding the company, he worked as a Principal at The Johns Hopkins University and as an Assistant Professor at Rowan University and the University of Michigan.
Frazee earned a doctorate degree from the University of Minnesota.
Aktive Positionen von Richard W. Frazee
| Unternehmen | Position | Beginn |
|---|---|---|
Secretory IgA, Inc.
 Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Gründer | 20.09.2011 |
Ehemalige bekannte Positionen von Richard W. Frazee
| Unternehmen | Position | Ende |
|---|---|---|
| University of Michigan | Corporate Officer/Principal | - |
| The Johns Hopkins University | Corporate Officer/Principal | - |
| Rowan University | Corporate Officer/Principal | - |
Ausbildung von Richard W. Frazee
| University of Minnesota | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Secretory IgA, Inc.
Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |
